MAGNIFY · Project

Artificial Muscles for Robots: Lightweight, Flexible Actuators Built from Molecular Machines

manufacturingPrototypeTRL 3Thin data (2/5)

Imagine billions of tiny molecular machines — each one smaller than a virus — all pulling in the same direction at once, like a crowd doing a stadium wave. The MAGNIFY team wove these molecular machines into ultra-thin polymer fibers using a technique called electrospinning, then bundled the fibers together to create something that works like a muscle. When you zap it with electricity, the molecular machines move, the fibers contract, and you get motion — from nano-scale all the way up to something you can see and use. The end goal is a new kind of actuator for robots that is lighter, more flexible, and more responsive than anything available today.

By the numbers

EUR 2,922,730

EU funding for artificial muscle research

consortium partners across 3 countries

total project deliverables

demo deliverables including working nanofiber prototypes

industry ratio in consortium — purely academic

The business problem

What needed solving

Current robotic actuators — electric motors, pneumatics, hydraulics — are heavy, rigid, and energy-hungry. For applications like wearable robots, prosthetics, and soft grippers, these traditional actuators are the bottleneck. Industry needs lightweight, flexible actuators that can mimic the properties of biological muscle: strong, fast, and able to change stiffness on demand.

The solution

What was built

The team built first-generation prototypes of three core components: a rotaxane monomer (the molecular building block), a synchronous-movement mechanism (to coordinate billions of molecular machines), and metal-coated core-shell nanofibers embedded with molecular motors. These are the foundational pieces of a new type of electrically-controlled artificial muscle.

Audience

Who needs this

Soft robotics companies developing wearable exoskeletons or prosthetic limbsRobotic gripper manufacturers needing gentle, tunable actuators for fragile goodsAerospace firms seeking ultra-lightweight actuators for micro-drones or morphing structuresMedical device companies working on minimally invasive surgical robotsResearch labs commercializing bio-inspired robotic systems

Business applications

Who can put this to work

Soft Robotics & Prosthetics

SME

Target: Robotic actuator manufacturers and prosthetics companies

If you are a prosthetics or soft robotics company struggling with heavy, rigid motors that limit wearable comfort — this project developed first-generation artificial muscle fibers controlled by electrical signals. These nanofiber-based actuators aim for high force-to-weight ratio and intrinsic rigidity tuning, which could replace bulky servo motors in lightweight wearable devices. The consortium of 5 partners across 3 countries produced working prototypes of the core components.

Industrial Automation

mid-size

Target: Manufacturers of grippers, assembly robots, and precision handling equipment

If you are an automation company looking for actuators that can handle delicate objects without crushing them — this project built a synchronous-movement mechanism and metal-coated core-shell nanofibers that respond to electrical stimuli. Unlike pneumatic or hydraulic systems, these artificial muscles offer flexibility and fast reaction with no compressor or fluid lines needed. The technology is still at research stage but targets the kind of gentle, tunable grip that rigid actuators cannot achieve.

Aerospace & Defense

enterprise

Target: Manufacturers of micro-drones, morphing wing systems, and lightweight actuators

If you are an aerospace firm where every gram counts and you need actuators that flex rather than rotate — this project's electrospun nanofiber bundles aim for high force-to-weight ratio and fast response. The team demonstrated first-generation molecular motor fibers and synchronous movement mechanisms across 10 deliverables over 5 years. This could eventually replace heavy mechanical linkages in micro-UAV control surfaces or deployable structures.

Frequently asked

Quick answers

What would it cost to license or access this technology?

No pricing or licensing terms are published in the project data. The consortium is entirely academic — 3 universities and 2 research organizations — so licensing would likely go through the university technology transfer office at Rijksuniversiteit Groningen. Based on available project data, expect early-stage research licensing terms rather than production-ready packages.

Can this scale to industrial production?

Not yet. The deliverables describe first-generation components: a rotaxane monomer, a synchronous-movement mechanism, and metal-coated core-shell nanofibers. These are laboratory-scale demonstrations. Scaling electrospun nanofiber bundles into mass-produced actuators would require significant additional engineering and industrial partnerships, neither of which are part of this consortium.

Who owns the intellectual property?

IP is shared among the 5 consortium partners across the Netherlands, France, and Italy under standard Horizon 2020 rules. Each partner typically owns the IP they generate. For licensing inquiries, the coordinator at Rijksuniversiteit Groningen would be the first point of contact.

How does this compare to existing actuator technologies?

Traditional robotic actuators use electric motors, pneumatics, or hydraulics — all heavy and rigid. This project targets artificial muscles with high force-to-weight ratio, flexibility, and tunable rigidity from a single material. Based on available project data, direct performance benchmarks against commercial actuators are not published in the deliverable descriptions.

What is the realistic timeline to a commercial product?

The project ran from 2018 to 2023 under FET Open funding, which targets breakthrough research at low technology readiness. With first-generation prototypes delivered and no industrial partners in the consortium, a commercial product is likely 7-10+ years away. Significant follow-on funding and industry collaboration would be needed.

Are there any regulatory hurdles?

Actuator technologies for general industrial robotics face standard machinery safety regulations (e.g., EU Machinery Directive). If used in medical prosthetics, the technology would need to pass medical device certification (MDR in Europe, FDA in the US). Based on available project data, no regulatory work has been initiated.

Consortium

Who built it

The MAGNIFY consortium is a purely academic team: 3 universities and 2 research organizations across 3 countries (Netherlands, France, Italy), with zero industry partners and zero SMEs. This is typical for FET Open projects targeting foundational science. The coordinator, Rijksuniversiteit Groningen, is a major Dutch research university with strong chemistry credentials. For a business considering this technology, the absence of industrial partners means no one has yet validated manufacturability or commercial viability — but it also means the IP landscape may be cleaner and licensing negotiations simpler, since all partners are public institutions with technology transfer offices.

RIJKSUNIVERSITEIT GRONINGENCoordinator · NL
UNIVERSITE DE STRASBOURGthirdparty · FR
CONSIGLIO NAZIONALE DELLE RICERCHEparticipant · IT
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNAparticipant · IT
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSparticipant · FR

How to reach the team

Rijksuniversiteit Groningen, Netherlands — reach out via their technology transfer office or the project website contact page

Order a report on this consortium See RIJKSUNIVERSITEIT GRONINGEN profile →

Next steps

Talk to the team behind this work.

Want to explore licensing this artificial muscle technology or connect with the research team? SciTransfer can arrange an introduction and help you evaluate the business case.

Order a report on this topic More in Manufacturing & Industry 4.0